These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 24865315
1. The appearance of dextranomer-hyaluronic acid copolymer implants on ultrasound may predict resolution of vesicoureteral reflux after injection therapy. Park KJ, Jeon TY, Yoo SY, Kim JH, Eo H, Song KD. Clin Radiol; 2014 Sep; 69(9):939-44. PubMed ID: 24865315 [Abstract] [Full Text] [Related]
2. Presence of dextranomer-hyaluronic acid (DxHA) mound on postoperative ultrasound does not predict resolution of vesicoureteral reflux. Ellsworth PI, Yates JK, Caldamone AA. J Pediatr Urol; 2011 Aug; 7(4):438-40. PubMed ID: 21672652 [Abstract] [Full Text] [Related]
3. Is routine voiding cystourethrogram necessary following double hit for primary vesicoureteral reflux? Arlen AM, Scherz HC, Filimon E, Leong T, Kirsch AJ. J Pediatr Urol; 2015 Feb; 11(1):40.e1-5. PubMed ID: 25725613 [Abstract] [Full Text] [Related]
4. Long-term ultrasound appearance of concomitant autologous blood and dextranomer/hyaluronic acid copolymer implants: is it associated with successful correction of vesicoureteral reflux? Kajbafzadeh AM, Aryan Z, Tourchi A, Alizadeh H. Urology; 2013 Feb; 81(2):407-13. PubMed ID: 23374819 [Abstract] [Full Text] [Related]
5. VUR timing on VCUG as a predictive factor of VUR resolution after endoscopic therapy. Lee JN, Lee SM, Ha YS, Kim BS, Kim HT, Kim TH, Yoo ES, Kwon TG, Chung SK. J Pediatr Urol; 2016 Aug; 12(4):255.e1-6. PubMed ID: 27220472 [Abstract] [Full Text] [Related]
6. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter? Dogan HS, Altan M, Citamak B, Bozaci AC, Koni A, Tekgul S. J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422 [Abstract] [Full Text] [Related]
7. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience. Kirsch AJ, Perez-Brayfield MR, Scherz HC. J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692 [Abstract] [Full Text] [Related]
8. Bladder ultrasound in the evaluation of the efficacy of dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Ozcan C, Ergün R, Ozbek SS, Avanoğlu A, Ulman I. J Clin Ultrasound; 2007 Sep; 35(7):357-62. PubMed ID: 17523192 [Abstract] [Full Text] [Related]
9. Can we rely on the presence of dextranomer-hyaluronic acid copolymer mounds on ultrasound to predict vesicoureteral reflux resolution after injection therapy? Zamilpa I, Koyle MA, Grady RW, Joyner BD, Shnorhavorian M, Lendvay TS. J Urol; 2011 Jun; 185(6 Suppl):2536-41. PubMed ID: 21555031 [Abstract] [Full Text] [Related]
10. Outcomes of vesicoureteral reflux in children with non-neurogenic lower urinary tract dysfunction treated with dextranomer/hyaluronic acid copolymer (Deflux). Van Batavia JP, Nees SN, Fast AM, Combs AJ, Glassberg KI. J Pediatr Urol; 2014 Jun; 10(3):482-7. PubMed ID: 24290224 [Abstract] [Full Text] [Related]
11. Routine delayed voiding cystourethography after initial successful endoscopic treatment with Dextranomer/Hialuronic Acid Copolimer (Dx/HA) of vesicoureteral reflux (VUR). Is it necessary? García-Aparicio L, Blázquez-Gómez E, Vila Santandreu A, Camacho Diaz JA, Vila-Cots J, Ramos Cebrian M, de Haro I, Martin O, Tarrado X. Actas Urol Esp; 2016 Dec; 40(10):635-639. PubMed ID: 27161091 [Abstract] [Full Text] [Related]
12. Endoscopic injection of dextranomer hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters. Molitierno JA, Scherz HC, Kirsch AJ. J Pediatr Urol; 2008 Oct; 4(5):372-6. PubMed ID: 18790423 [Abstract] [Full Text] [Related]
14. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review. Chung KLY, Sihoe J, Liu K, Chao N, Hung J, Liu C, Yam F, Leung Y, Tam P, Lee KH, Leung M. J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690 [Abstract] [Full Text] [Related]
15. Appearance of dextranomer/hyaluronic Acid copolymer implants on computerized tomography after endoscopic treatment of vesicoureteral reflux in children. Cerwinka WH, Qian J, Easley KA, Scherz HC, Kirsch AJ. J Urol; 2009 Mar; 181(3):1324-8; discussion 1329. PubMed ID: 19157427 [Abstract] [Full Text] [Related]
16. The reliability of VCUG performed within 24 hours after injection of dextranomer/hyaluronic acid in patients with vesico-ureteral reflux. Oh MM, Park MG, Kim JW, Yoo KH, Lee JW, Yoon CY, Park HS, Moon du G. Urology; 2014 Jan; 83(1):191-4. PubMed ID: 24041674 [Abstract] [Full Text] [Related]
17. Endoscopic hyaluronic acid/dextranomer gel implantation is effective as first-line treatment of vesicoureteral reflux (VUR) in children: a single centre experience. Häcker FM, Frech-Dörfler M, von Rotz M, Rudin C. Eur J Pediatr Surg; 2011 Oct; 21(5):299-303. PubMed ID: 21688236 [Abstract] [Full Text] [Related]
19. Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR). García-Aparicio L, Blázquez-Gómez E, Martin O, Pérez-Bertólez S, Arboleda J, Soria A, Tarrado X. World J Urol; 2018 Oct; 36(10):1651-1656. PubMed ID: 29725806 [Abstract] [Full Text] [Related]
20. Dextranomer-Hyaluronic Acid and Polyacrylate-Polyalcohol Copolymer are Equally Efficient for Endoscopic Treatment of Vesicoureteral Reflux in Children. Bele U, Bratus D. Urol J; 2019 Aug 18; 16(4):361-365. PubMed ID: 30318569 [Abstract] [Full Text] [Related] Page: [Next] [New Search]